Skip to main content

FDA considering half-dose of Moderna vaccine as booster

The Food and Drug Administration is leaning toward approving a half-dose of Moderna’s COVID-19 vaccine as a booster shot, according to a report.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.